Tonix Pharmaceuticals Holding (TNXP) Change in Receivables (2024 - 2026)

Tonix Pharmaceuticals Holding's Change in Receivables history runs 3 years deep, the most recent figure standing at $2.5 million for Q1 2026.

• On a quarterly basis, Change in Receivables rose 786.79% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $5.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.6 million, down 28.89% from the prior year.
• Change in Receivables slipped to $2.5 million in Q1 2026 per TNXP's latest filing, from $2.8 million in the prior quarter.
• Across five years, Change in Receivables topped out at $2.8 million in Q4 2025 and bottomed at -$1.3 million in Q4 2024.
• The 3-year median for Change in Receivables is $1.2 million (2025), against an average of $787285.7.
• Across the five-year window, Change in Receivables decreased 27.39% in 2025 and jumped 786.79% in 2026, its largest moves.
• Year by year, Change in Receivables stood at -$1.3 million in 2024, then jumped by 314.7% to $2.8 million in 2025, then decreased by 8.64% to $2.5 million in 2026.
• Per Business Quant, the three latest TNXP Change in Receivables figures stand at $2.5 million (Q1 2026), $2.8 million (Q4 2025), and $1.2 million (Q3 2025).